Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Gamma Delta T Cell Immunotherapy + Chemoimmunotherapy for Neuroblastoma
Recruiting3 awardsPhase 1
Atlanta, Georgia
This trial is testing a new immunotherapy treatment for neuroblastoma that uses gamma delta T cells in combination with other drugs. The goal is to improve upon GD2 chemoimmunotherapy regimens for neuroblastoma by delivering standard drugs like temozolomide, irinotecan, and dinutuximab in combination with gamma delta T cells.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.